The NPY system in stress, anxiety and depression

Neuropeptides
Markus Heilig

Abstract

NPY antagonizes behavioral consequences of stress through actions within the brain. Behavioral anti-stress actions of NPY are noteworthy in that (1) their magnitude surpasses that of other endogenous compounds; (2) they are produced across a wide range of animal models, normally thought to reflect different aspects of emotionality. This suggests that NPY acts with a high potency on a common core mechanism of emotionality and behavioral stress responses. Behavioral studies in genetically modified animals support this hypothesis. Increased emotionality is seen upon inactivation of NPY transmission, while the opposite is found when NPY signalling is made overactive. Several brain structures are involved in mediating anti-stress actions of NPY, with the most extensive evidence available for amygdala and hippocampus, and some evidence for regions within the septum, and locus coeruleus. Antistress actions of NPY are mimicked by Y1-receptor agonists, and blocked by Y1 antagonists, although Y5 receptors may substitute for Y1 actions in some cases. Blockade of Y2 receptors produces anti-stress effects indistinguishable from those produced by Y1 agonism, presumably through potentiation of presynaptic release of endogenous NPY. Together, ...Continue Reading

Associated Clinical Trials

References

Jul 1, 1992·Journal of Neurochemistry·P S WiddowsonA E Halaris
Jan 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·J FuhlendorffT W Schwartz
Dec 1, 1987·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·W H BerrettiniD Pickar
May 7, 1987·European Journal of Pharmacology·M Heilig, R Murison
Jan 1, 1971·Psychopharmacologia·J R VogelD E Clody
Feb 1, 1994·Trends in Neurosciences·M HeiligK T Britton
Dec 27, 1994·European Journal of Pharmacology·K RudolfH N Doods
Jan 1, 1994·Neuroscience and Biobehavioral Reviews·M L BrandãoN C Coimbra
Jun 1, 1993·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·M HeiligK T Britton
Feb 1, 1993·Neurochemistry International·R Bellmann, G Sperk
Mar 1, 1996·International Clinical Psychopharmacology·P Baumann
Jul 1, 1997·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·C L EhlersJ E Rivier
Aug 28, 1998·Trends in Neurosciences·L W Swanson, G D Petrovich
Oct 13, 1998·Psychopharmacology·C L EhlersD Cloutier

❮ Previous
Next ❯

Citations

Feb 9, 2011·Archives of General Psychiatry·Brian J MickeyJon-Kar Zubieta
Feb 24, 2006·Naunyn-Schmiedeberg's Archives of Pharmacology·Elaine C Gavioli, Girolamo Calo'
Sep 17, 2011·European Journal of Applied Physiology·R RämsonJ Mäestu
Apr 7, 2011·Journal of Cardiovascular Translational Research·Lijun LiZofia Zukowska
Apr 18, 2013·Journal of the American Society for Mass Spectrometry·Ying ZhouRobert T Kennedy
Mar 21, 2013·Behavioural Brain Research·Sagar J DesaiDadasaheb M Kokare
Jun 12, 2013·Neuropharmacology·George F KoobOlivier George
Nov 13, 2013·Neuropeptides·M J Zaben, W P Gray
Feb 24, 2006·NeuroRx : the Journal of the American Society for Experimental NeuroTherapeutics·Asher B Simon, Jack M Gorman
Nov 12, 2013·Analytical Chemistry·Richard C MurdockJoshua A Hagen
Jul 5, 2012·Journal of Agricultural and Food Chemistry·Shiau-Wei ChenBeen-Huang Chiang
Jul 18, 2012·Molecular Psychiatry·R Sah, T D Geracioti
Oct 7, 2011·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Hagit CohenAleksander A Mathé
Jun 14, 2012·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·HaoSheng SunEric J Nestler
Jun 12, 2013·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Ulrike StadlbauerUrs Meyer
Jan 30, 2013·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Andrei I MoloshAnantha Shekhar
Jan 13, 2006·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Libor Velísek
Feb 9, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Tiziana RubinoDaniela Parolaro
Jan 4, 2008·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Eugenia KuteevaSven Ove Ogren
Oct 21, 2010·The Journal of Biological Chemistry·Raquel FerreiraJoão O Malva
Dec 14, 2011·Current Opinion in Psychiatry·Jozsef Haller, Mano Alicki
Aug 1, 2006·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·B Beck
Aug 31, 2006·Genes, Brain, and Behavior·S C GammieS A Stevenson
Mar 17, 2012·Science·G Shohat-OphirU Heberlein
Jun 26, 2012·Disease Models & Mechanisms·Sarah BaxendaleVincent T Cunliffe
Nov 9, 2007·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Smita Thakker-VariaJanet Alder
Nov 28, 2008·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Alisa R GutmanMichael Davis
Oct 26, 2007·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Udi E GhitzaYavin Shaham
Feb 7, 2013·The Journal of Endocrinology·Ladan EshkevariSusan E Mulroney
Aug 17, 2006·Nutritional Neuroscience·R BelooseskyM G Ross
Dec 3, 2013·Science·Christi M GendronScott D Pletcher

❮ Previous
Next ❯

Related Concepts

Related Feeds

Amygdala and Midbrain Dopamine

The midbrain dopamine system is widely studied for its involvement in emotional and motivational behavior. Some of these neurons receive information from the amygdala and project throughout the cortex. When the circuit and transmission of dopamine is disrupted symptoms may present. Here is the latest research on the amygdala and midbrain dopamine.

Amygdala: Sensory Processes

Amygdalae, nuclei clusters located in the temporal lobe of the brain, play a role in memory, emotional responses, and decision-making. Here is the latest research on sensory processes in the amygdala.

Brain Circuitry in Anxiety

Anxiety impacts the quality of everyday life and may facilitate the development of affective disorders, possibly through concurrent alterations in neural circuitry. Here is the latest research.